EVFM — Evofem Biosciences Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Evofem Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-9.99	-126	-80	-142	-205
Depreciation
Non-Cash Items	0.816	65.9	37.3	52.4	46.9
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.931	3.06	-12.7	-15.2	10.6
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-8.2	-56.5	-55.1	-105	-147
Capital Expenditures	0	-0.007	-0.164	-2.25	-2.94
Purchase of Fixed Assets
Other Investing Cash Flow Items	0.007	2.15	-7.95	8.48	0.25
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities	0.007	2.14	-8.12	6.23	-2.69
Financing Cash Flow Items	—	-3.01	-2.85	-3.74	-1.3
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.026	54.4	78.1	154	90.7
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-8.17	0.06	14.9	55.6	-58.7

Discover the metrics influencing Evofem Biosciences's share price